Morgan L Cheeks1, Rebecca Schwartz2, Elizabeth C Oleson3, Stephanie Cohen4, Eleanor A Drey5, Dominika Seidman5. 1. University of California San Francisco School of Medicine, San Francisco, CA, United States. Electronic address: morganlynncheeks@gmail.com. 2. University of California San Francisco Department of Obstetrics, Gynecology & Reproductive Sciences, San Francisco, CA, United States. 3. San Francisco Department of Public Health, San Francisco, CA, United States. 4. San Francisco Department of Public Health, Disease Prevention and Control Branch, San Francisco, CA, United States. 5. Department of Obstetrics, Gynecology & Reproductive Sciences, Zuckerberg San Francisco General Hospital, University of California San Francisco; Bixby Center for Global Reproductive Health, San Francisco, CA, United States.
Abstract
INTRODUCTION: The Centers for Disease Control and Prevention recommend considering screening asymptomatic women for trichomonas in high-prevalence settings. Whether urban abortion clinics constitute such a setting is unknown. MATERIAL AND METHODS: We offered trichomonas screening to patients presenting for abortion from October 2018 to February 2019 as a practice improvement and conducted a chart review. RESULTS: Ninety-two percent (593/644) of patients underwent testing. Trichomonas prevalence was 10.0% (95% CI 7.7-12.6). Ninety five percent of patients diagnosed were treated. Testing only symptomatic patients would have missed 98% of infections. CONCLUSIONS: Trichomonas was highly prevalent, and universal testing and treatment was feasible in an urban abortion clinic.
INTRODUCTION: The Centers for Disease Control and Prevention recommend considering screening asymptomatic women for trichomonas in high-prevalence settings. Whether urban abortion clinics constitute such a setting is unknown. MATERIAL AND METHODS: We offered trichomonas screening to patients presenting for abortion from October 2018 to February 2019 as a practice improvement and conducted a chart review. RESULTS: Ninety-two percent (593/644) of patients underwent testing. Trichomonas prevalence was 10.0% (95% CI 7.7-12.6). Ninety five percent of patients diagnosed were treated. Testing only symptomatic patients would have missed 98% of infections. CONCLUSIONS: Trichomonas was highly prevalent, and universal testing and treatment was feasible in an urban abortion clinic.